Stability and reliability
“In 2012, we purchased an IBA accelerator for our production center based in Wuxi, Jiangsu Province, China. By using this high-tech sterilization equipment, the whole team of Wuxi Nest has been working relentlessly to sterilize millions of Covid PCR tests. Through our own efforts, and thanks to the stability and reliability of the Rhodotron®, we are proud to say we have contributed to the fight against this pandemic.”
IBA Industrial, your irradiation partner
It all started with a dream.
The first of our dreamers was Yves Jongen, IBA’s founder. As director of the Cyclotron Research Center in Louvain-la-Neuve, Belgium, he dreamt to reduce the size and cost of the cyclotron, making it more accessible to all who might need it. Something nobody thought was even possible at the time.
Until 1986, when his dream became a reality. And IBA was born.
Since then, IBA has always aimed to protect, enhance and save lives by pushing further and further the limits of technology and innovation. Because we know that dreams really do come true.
Today, together with you, we go beyond.
We are proud to be part of an inspiring, inspired company. As a world leader in electron-based irradiation solutions for industry, we strive everyday to help dreamers like us to achieve their dreams.
And tomorrow? We keep dreaming.
Protecting, enhancing and saving lives is the core of our business. Our raison d’être. The well-being of our customers and patients, our employees, our society, our planet and our shareholders is our number one priority.
Going beyond the limits of imagination requires boldness, audacity, and most of all, genuine passion. We dare to create, to innovate, to search for better and more efficient results in everything we pursue. We dare to dream, and to achieve our dreams. We dare to go beyond.
Because we are stronger together, we share our ideas, our expertise, and our solutions with you – and all our shareholders. Unity makes strength. And we believe that total transparency will only allow us to go further, together.
Your trust is essential to us. And we intend to remain worthy of it. We are fair to each life and keep the highest ethical standards to fulfill our mission: protect, enhance, save lives. Always. And beyond.
Business as a force for good
IBA’s business model is based on the constant search for balance, between our shareholders, our clients and their patients, our employees, our society and our planet.
B Corp certified
We are proud to have demonstrated our socially and environmentally responsible practices to the prestigious B Corp organization. Through rigorous observation of IBA’s operations, B Corp assessed that we meet some of the highest standards in the fields of health, energy, transparency, welfare, and more.
Because protecting, enhancing and saving lives requires constant research and development, IBA focuses on creating strategic R&D partnerships. We keep pushing further and further the limits of science to provide state-of-the-art technology to our customers and their patients.
We believe in the power of unity. And to fulfill our mission, we surround ourselves with the most reliable clinical, scientific and industrial partners and suppliers from around the world. Because we know that sharing knowledge and expertise is the best way towards constant innovation. We go beyond expectations, together.
Founding of IBA
Founded by Yves Jongen in 1986, IBA is as a spin-off of the Cyclotron Research Center of the Catholic University of Louvain-la-Neuve (UCL), Belgium. Initially active in medical imaging, the company turned its attention to radiotherapy and developed cyclotrons and integrated proton therapy centers which are able to treat numerous forms of cancer with a degree of precision and efficacy never reached before.
IBA expands its activities
In 1992, IBA expands activities into the industrial sector of sterilization and ionization by introducing the Rhodotron®, a new type of particle accelerator producing an electron beam based on a patented concept of the French Atomic Energy Commission.
Employee’s Buy Out
IBA employees got together in 1997 in an employee buyout of the shares of the company. The purpose was to raise their involvement in, and reward their commitment to, the success of the company while also giving themselves the opportunity to drive its future.
IBA enters the Brussels stock market
In June 1998, funds are raised on the Brussels stock market from an initial public offering to enable IBA to accelerate development through internal growth and acquisitions.
IBA consolidates its strength in irradiation technologies
IBA consolidates its strength in irradiation technologies with the acquisition of Radiation Dynamics, Inc. in February 1999. RDI was well established in the field of high-power low-energy E-beam accelerators used for heat shrinking and polymer modification applications.
This acquisition reinforced IBA’s prominent position in the electron beam field as the RDI product line complements nicely IBA’s high energy, high power Rhodotrons®. Adding a very large installed base (more than 200 units) essentially in the US, RDI has also served as a stronghold for the development of IBA accelerator business in North America.
IBA sells Sterigenics
5 years after the company’s acquisition, IBA having gained a strong experience in building and operating a sterilization center sells Sterigenics and focuses on equipment supply.
Developing presence in Asia
In June 2007, IBA opens a new facility in Beijing, China, giving the company Asian Headquarters to support all its business units in Asia. This move is part of an overall development program to optimize opportunities in one of the world’s fastest growing markets.
Olivier Legrain appointed as Chief Executive Officer of IBA
Olivier Legrain becomes Chief Executive Officer replacing Pierre Mottet. Olivier Legrain joined the company in 1996 as Financial Controller. He further pursued his career in the company as President of the IBA Dosimetry business line from 1999 to 2003. From 2003 till 2010 he became President of the IBA Molecular business line. Thereafter he took over the role of Chief Strategy Officer of the Group.
Yves Jongen nominated for the European Inventor Award
Yves Jongen, Founder and Chief Research Officer of IBA, is nominated for the European Inventor of the Year Award from the European Patent Office for his lifetime contribution to developing new solutions in proton therapy and making this next generation targeted cancer treatment more accessible to cancer patients worldwide.
IBA CELEBRATES ITS 30TH ANNIVERSARY
On September 6th 2016, IBA’s iconic representatives rejoined to celebrate 30 years of successes, dreams and challenges. Yves Jongen, Olivier Legrain and Pierre Mottet marked the occasion for those three decades of passion with more than 600 participants, by pledging to pursue their objective: “to contribute to a better quality of life for patients, for its customers, its employees, its shareholders, the community, and in general for the generations of today and tomorrow everywhere in the world”.
IBA CELEBRATES 35 YEARS OF SUCCESS
For its 35th anniversary, Yves Jongen, IBA’s founder, announced the launch of its latest cyclotron: the Cyclone® IKON. This new generation high energy cyclotron is more efficient than ever: light yet powerful, compact yet robust, the Cyclone® IKON takes IBA’s technology to the next level, with a 13 to 30 MeV energy range.
IBA Industrial GOES BEYOND™… EXPECTATIONS
After two years of COVID, the sterilization market rebounded and started growing again – fast. To capture it, IBA had to go beyond all expectations; that’s when BEYOND™ was born. Powered by the iconic Rhodotron® technology, the BEYOND™ solutions offer irradiation solutions either by E-beam or X-ray, or both. From then on, IBA Industrial became more than an innovative technology provider to their customers: they became partners. Lifelong partners, engaged for a journey … to infinity, and beyond.
IBA in Key figures
In 25 countries
and patents applications
Today, more than 25 service centers have trusted IBA and equipped their facilities with a Rhodotron®.
In many years, unanticipated downtime approached 0%.
For 45 years IBA Industrial has supported the Dynamitron® installation in Gaithersburg, MD. This machine is an important part of our customers supply chain. IBA support has helped us maintain unanticipated downtime well below 2%, in many years it has approached 0%. Gaithersburg has never been disappointed in the response of IBA.
Professionalism, reliability, speed.
In IONISOS IBÉRICA, we are very pleased to have IBA in charge of the maintenance and technical support of our Rhodotron®. We emphasize, among many other positive aspects, professionalism, reliability, speed and willingness to resolve any problems that may arise in order to secure our production.